{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:53:30Z","timestamp":1788519210480,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijbiomac.2023.126561","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:03:03Z","timestamp":1693515783000},"page":"126561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P1","title":["Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective"],"prefix":"10.1016","volume":"253","author":[{"given":"Mounisha","family":"Bandakinda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7863-5581","authenticated-orcid":false,"given":"Awanish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijbiomac.2023.126561_bb0005","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/healthcare10101845","article-title":"Leveraging mHealth and virtual reality to improve cognition for Alzheimer\u2019s patients: a systematic review","volume":"10","author":"Kruse","year":"2022","journal-title":"Healthcare (Basel)."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/jpn.0442","article-title":"Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer\u2019s disease","volume":"29","author":"Kar","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0015","first-page":"90","article-title":"DNA methylation: a promising approach in management of Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"11","author":"Kaur","year":"2022","journal-title":"Biology (Basel)."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126561_bb0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s11011-021-00806-4","article-title":"Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside","volume":"36","author":"Mishra","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.126561_bb0025","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.3390\/molecules26216456","article-title":"Neuroprotective potential of chrysin: mechanistic insights and therapeutic potential for neurological disorders","volume":"26","author":"Mishra","year":"2021","journal-title":"Molecules."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbr.2010.05.033","article-title":"The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-\u03b242 with memantine","volume":"221","author":"Nyakas","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0306-4522(02)00404-9","article-title":"Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures","volume":"115","author":"Zheng","year":"2002","journal-title":"Neuroscience."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/revneuro-2017-0042","article-title":"MicroRNA in Alzheimer\u2019s disease revisited: implications for major neuropathological mechanisms","volume":"29","author":"Dehghani","year":"2018","journal-title":"Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0050","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/biom12111676","article-title":"Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer\u2019s disease and identifying promising drug targets","volume":"12","author":"Fi\u0161ar","year":"2022","journal-title":"Biomolecules."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.126561_bb0055","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2174\/1568026620666200416085330","article-title":"Role of flavonoids in neurodegenerative diseases: limitations and future perspectives","volume":"20","author":"Maan","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22478","article-title":"Role of curcumin and its nanoformulations in neurotherapeutics: a comprehensive review","volume":"34","author":"Mandal","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fneur.2020.00288","article-title":"The regulation of microRNAs in Alzheimer\u2019s disease","volume":"17","author":"Kou","year":"2020","journal-title":"Front. Neurol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.126561_bb0070","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3390\/ijms20163979","article-title":"Role of miRNAs in Alzheimer\u2019s disease and possible fields of application","volume":"20","author":"Silvestro","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fgene.2019.00153","article-title":"MicroRNAs in Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front Genet."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.126561_bb0080","article-title":"The eminent role of microRNAs in the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Samadian","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.126561_bb0085","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.3390\/ijms23147992","article-title":"miR-143-3p inhibits aberrant tau phosphorylation and amyloidogenic processing of APP by directly targeting DAPK1 in Alzheimer\u2019s disease","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126561_bb0090","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jmb.2019.01.046","article-title":"Emerging role of microRNAs in dementia","volume":"431","author":"Ramakrishna","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13024-021-00496-7","article-title":"The promise of microRNA-based therapies in Alzheimer\u2019s disease: challenges and perspectives","volume":"16","author":"Walgrave","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101529","article-title":"Deregulated mitochondrial microRNAs in Alzheimer\u2019s disease: focus on synapse and mitochondria","volume":"73","author":"Gowda","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126561_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165937","article-title":"The role of synaptic microRNAs in Alzheimer\u2019s disease","volume":"1866","author":"Kumar","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.785433","article-title":"Inflamma-MicroRNAs in Alzheimer\u2019s disease: from disease pathogenesis to therapeutic potentials","volume":"15","author":"Liang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108725","article-title":"MicroRNA mediated regulation of the major redox homeostasis switch, Nrf2, and its impact on oxidative stress-induced ischemic\/reperfusion injury","volume":"698","author":"Padmavathi","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"14","key":"10.1016\/j.ijbiomac.2023.126561_bb0120","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.3390\/ijms23147789","article-title":"The potential role of miRNA-regulated autophagy in Alzheimer\u2019s disease","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126561_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126423","article-title":"MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer\u2019s disease","volume":"10","author":"Denk","year":"2015","journal-title":"PLoS One"},{"issue":"10043","key":"10.1016\/j.ijbiomac.2023.126561_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0145","first-page":"1060","article-title":"The pathophysiology of Alzheimer's disease with special reference to \"amyloid cascade hypothesis\"","volume":"61","author":"Tamaoka","year":"2013","journal-title":"Rinsho Byori."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0150","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3892\/mmr.2017.7301","article-title":"Expression of microRNA-222 in serum of patients with Alzheimer\u2019s disease","volume":"16","author":"Zeng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/1533317520911573","article-title":"Whole-blood levels of microRNA-9 are decreased in patients with late-onset Alzheimer disease","volume":"35","author":"Souza","year":"2020","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.126561_bb0160","article-title":"Elevated expression of MiR-17 in microglia of Alzheimer\u2019s disease patients abrogates autophagy-mediated amyloid-\u03b2 degradation","volume":"27","author":"Estfanous","year":"2021","journal-title":"Front. Immunol."},{"issue":"169","key":"10.1016\/j.ijbiomac.2023.126561_bb0165","article-title":"Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population","volume":"23","author":"Abuelezz","year":"2022","journal-title":"Exp. Gerontol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.126561_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fnins.2019.00430","article-title":"Amyloid beta and MicroRNAs in Alzheimer\u2019s disease","volume":"3","author":"Amakiri","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0175","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","article-title":"MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer\u2019s-associated pathogenesis in SAMP8 mice","volume":"33","author":"Liu","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3892\/ijmm.2014.1780","article-title":"MicroRNA-384 regulates both amyloid precursor protein and \u03b2-secretase expression and is a potential biomarker for Alzheimer\u2019s disease","volume":"34","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0185","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.3892\/mmr.2015.3728","article-title":"MicroRNA-29c targets \u03b2-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0190","article-title":"Circulating micro-RNAs \u03b2differentially expressed in Korean Alzheimer\u2019s patients with brain a accumulation activate amyloidogenesis","volume":"9","author":"Mankhong","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"463","key":"10.1016\/j.ijbiomac.2023.126561_bb0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroscience.2021.03.028","article-title":"MicroRNA-4422-5p as a negative regulator of amyloidogenic secretases: a potential biomarker for Alzheimer\u2019s disease","volume":"21","author":"Hajjari","year":"2021","journal-title":"Neuroscience."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jnr.10161","article-title":"Participation of structural microtubule-associated proteins (MAPs) in the development of neuronal polarity","volume":"67","author":"Gonz\u00e1lez-Billault","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0210","first-page":"89","article-title":"Neurofibrillary tangles of Alzheimer\u2019s disease: an immunohistochemical study","volume":"17","author":"Brion","year":"1985","journal-title":"J. Submicrosc. Cytol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0215","doi-asserted-by":"crossref","first-page":"30953","DOI":"10.1038\/srep30953","article-title":"microRNA-132\/212 deficiency enhances A\u03b2 production and senile plaque deposition in Alzheimer\u2019s disease triple transgenic mice","volume":"3","author":"Hernandez-Rapp","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126561_bb0220","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.3390\/ijms22073653","article-title":"Candidate Alzheimer\u2019s disease biomarker miR-483-5p lowers TAU phosphorylation by direct ERK1\/2 repression","volume":"22","author":"Nagaraj","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"172","key":"10.1016\/j.ijbiomac.2023.126561_bb0225","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","article-title":"Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: focus on aging, mitochondria and synapse","volume":"20","author":"Morton","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2010.09.079","article-title":"Increased expression of miRNA-146a in Alzheimer\u2019s disease transgenic mouse models","volume":"487","author":"Li","year":"2011","journal-title":"Neurosci Lett."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.126561_bb0235","article-title":"Reduced levels of miR-342-5p in plasma are associated with worse cognitive evolution in patients with mild Alzheimer\u2019s disease","volume":"23","author":"Dakterzada","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0240","doi-asserted-by":"crossref","first-page":"15589","DOI":"10.1038\/s41598-022-19862-6","article-title":"Plasma microRNAs as potential biomarkers in early Alzheimer disease expression","volume":"12","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0245","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jnr.24781","article-title":"Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer\u2019s disease","volume":"99","author":"Medala","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0250","doi-asserted-by":"crossref","first-page":"101191","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0255","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3233\/JAD-215139","article-title":"Synaptic mitochondria: an early target of amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"84","author":"Torres","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0260","article-title":"Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer\u2019s patients: a potential biomarker for Alzheimer\u2019s disease","volume":"1867","author":"Kumar","year":"2021","journal-title":"BiochimBiophys Acta Mol Basis Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126561_bb0265","first-page":"476","article-title":"Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation","volume":"17","author":"Brites","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0270","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16019166","article-title":"MicroRNA-139 modulates Alzheimer\u2019s-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2","volume":"16","author":"Tang","year":"2017","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0275","article-title":"Inflammation-related microRNAs-146a and \u2212155 are upregulated in mild cognitive impairment subjects among older age population in Montenegro","author":"Dragovi\u0107","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0280","doi-asserted-by":"crossref","first-page":"135542","DOI":"10.1016\/j.neulet.2020.135542","article-title":"MicroRNA-20b-5p aggravates neuronal apoptosis induced by \u03b2-amyloid via down-regulation of Ras homolog family member C in Alzheimer\u2019s disease","volume":"742","author":"Tian","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/MCB.00589-15","article-title":"Regulation of neuronal cell cycle and apoptosis by MicroRNA 34a","volume":"36","author":"Modi","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"2021","key":"10.1016\/j.ijbiomac.2023.126561_bb0290","article-title":"miR-590-3 and SP1 promote neuronal apoptosis in patients with Alzheimer\u2019s disease via AMPK signaling pathway","volume":"15","author":"Cao","year":"2021","journal-title":"Contrast Media Mol Imaging."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0295","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2174\/1567205014666170829101016","article-title":"miRNAs in Alzheimer disease - a therapeutic perspective","volume":"14","author":"Gupta","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0300","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","article-title":"Antisense oligonucleotides: treating neurodegeneration at thelevel of RNA","volume":"10","author":"DeVos","year":"2013","journal-title":"Neurotherapeutics."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0310","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s13238-014-0022-7","article-title":"MicroRNA-29a modulates axon branching by targeting doublecortin in primary neurons","volume":"5","author":"Li","year":"2014","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0315","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbrc.2017.11.122","article-title":"Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer\u2019s disease biomarkers","volume":"495","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0320","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-161179","article-title":"MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples","volume":"57","author":"Riancho","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0325","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.12659\/MSM.905064","article-title":"Genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease","volume":"23","author":"Chang","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126561_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cbf.3184","article-title":"Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease","volume":"34","author":"Jia","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0335","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-150619","article-title":"Circulating microRNAs as biomarkers of Alzheimer\u2019s disease: a systematic review","volume":"49","author":"Wu","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126561_bb0340","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1007\/s12035-015-9484-8","article-title":"Peripheral blood MicroRNA expression profiles in Alzheimer\u2019s disease: screening, validation, association with clinical phenotype and implications for molecular mechanism","volume":"53","author":"Ren","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and -200b, potential biomarkers for Alzheimer\u2019s disease, regulate \u03b2 secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.126561_bb0350","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnagi.2018.00041","article-title":"MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update","volume":"10","author":"Kumar","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.126561_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnagi.2018.00041","article-title":"MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update","volume":"23","author":"Kumar","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126561_bb0365","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer\u2019s disease","volume":"5","author":"Hara","year":"2017","journal-title":"Acta Neuropathol Commun."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0370","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","article-title":"MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-\u03b2 production by targeting BACE1","volume":"88","author":"Zhu","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0375","doi-asserted-by":"crossref","first-page":"136881","DOI":"10.1016\/j.neulet.2022.136881","article-title":"Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats","volume":"789","author":"Rafiey","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0380","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","article-title":"miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease","volume":"478","author":"Liu","year":"2016","journal-title":"BiochemBiophys Res Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126561_bb0385","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3892\/etm.2016.3366","article-title":"MicroRNA-135b has a neuroprotective role via targeting of \u03b2-site APP-cleaving enzyme 1","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp Ther Med."},{"issue":"24","key":"10.1016\/j.ijbiomac.2023.126561_bb0390","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.12659\/MSM.908765","article-title":"Micro-RNA-137 inhibits tau hyperphosphorylation in Alzheimer\u2019s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells","volume":"13","author":"Jiang","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"367","key":"10.1016\/j.ijbiomac.2023.126561_bb0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2016.05.038","article-title":"Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice","volume":"15","author":"Zhou","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0400","article-title":"The role of microRNAs in neurodegenerative diseases: a review","volume":"1\u201331","author":"Li","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"1423","key":"10.1016\/j.ijbiomac.2023.126561_bb0405","article-title":"The risks of miRNA therapeutics: in a drug target perspective","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126561_bb0410","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s11011-019-00438-9","article-title":"Intrahippocampal miR-342-3p inhibition reduces \u03b2-amyloid plaques and ameliorates learning and memory in Alzheimer\u2019s disease","volume":"34","author":"Fu","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126561_bb0415","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.7150\/thno.47408","article-title":"Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer\u2019s disease by enhancing autophagy","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1627","article-title":"Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer\u2019s disease","volume":"10","author":"Han","year":"2020","journal-title":"Brain Behav."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.126561_bb0425","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.omtn.2020.01.010","article-title":"miRNA-31 improves cognition and abolishes amyloid-\u03b2 pathology by targeting APP and BACE1 in an animal model of Alzheimer\u2019s Disease","volume":"6","author":"Barros-Viegas","year":"2020","journal-title":"Mol Ther Nucleic Acids."},{"issue":"2022","key":"10.1016\/j.ijbiomac.2023.126561_bb0430","article-title":"miR-590-5p overexpression alleviates \u03b2-amyloid-induced neuron damage via targeting Pellino-1","volume":"8","author":"Shang","year":"2022","journal-title":"Anal Cell Pathol (Amst)."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147983","article-title":"Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p\/FOXO3a-PPM1F axis in APP\/PS1 mice","volume":"1790","author":"Fu","year":"2022","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0440","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150395","article-title":"miRNAs: KeyPlayers in neurodegenerative disorders and epilepsy","volume":"48","author":"Karnati","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126561_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2680","article-title":"MiR-483-3p improves learning and memory abilities via XPO1 in Alzheimer\u2019s disease","volume":"12","author":"Luo","year":"2022","journal-title":"Brain Behav."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0450","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.neurobiolaging.2014.11.020","article-title":"CCAAT\/enhancer-binding protein delta\/miR135a\/thrombospondin 1 axis mediates PGE2-induced angiogenesis in Alzheimer\u2019s disease","volume":"36","author":"Ko","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0455","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.3390\/cells10113097","article-title":"The challenges and opportunities in the development of MicroRNA therapeutics: a multidisciplinary viewpoint","volume":"10","author":"Momin","year":"2021","journal-title":"Cells."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126561_bb0460","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126561_bb0465","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2021.04.007","article-title":"Opportunities and challenges for microRNA-targeting therapeutics for epilepsy","volume":"42","author":"Morris","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126561_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112680","article-title":"MicroRNA therapeutics in cancer: current advances and challenges","volume":"13","author":"Reda El Sayed","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126561_bb0475","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin Drug Discov."},{"key":"10.1016\/j.ijbiomac.2023.126561_bb0480","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","article-title":"Therapeutic advances of miRNAs: a preclinical and clinical update","volume":"28","author":"Chakraborty","year":"2020","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126561_bb0485","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023034578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023034578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:37:48Z","timestamp":1758883068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023034578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":97,"alternative-id":["S0141813023034578"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126561","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126561"}}